{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:52:19Z","timestamp":1794873139595,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100022831","name":"Sa\u011fl\u0131k Bilimleri \u00dcniversitesi","doi-asserted-by":"publisher","award":["2023\/031"],"award-info":[{"award-number":["2023\/031"]}],"id":[{"id":"10.13039\/100022831","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Health Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>Spinal cord injury (SCI), which is characterized by motor and\/or sensory dysfunction, presents a significant health challenge resulting from mechanical trauma. Secondary injury, which follows the mechanical trauma and is driven by factors such as inflammation, plays a critical role in the SCI pathophysiology. Scientific evidence indicates that treatment strategies aimed at modulating inflammation during the acute phase of SCI alleviate the seconder injury. In this regard, the present study seeks to evaluate the effectiveness of certolizumab, a monoclonal antibody targeting TNF-\u03b1 that is widely used in the treatment of various inflammatory diseases, in a SCI model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this study, Control, Trauma, and Trauma\u2009+\u2009Certolizumab groups were established, each comprising eight male rats. One hour after SCI induction, rats in the Trauma\u2009+\u2009Certolizumab group were administered 10\u00a0\u00b5g Certolizumab dissolved in saline intraperitoneally, while rats in the Control and Trauma groups received an equivalent volume of saline. After Modified Tarlov Scoring was performed on the seventh day of the experiment, all rats were sacrificed. The effects of certolizumab on neuroinflammation and apoptosis in the SCI model were evaluated using histological, biochemical, and molecular analyses of blood and tissue samples obtained from the rats.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Certolizumab downregulated the expression of TNF-\u03b1, NF-\u03baB, and IL-6. In addition, as evidenced by the TUNEL assay, Caspase-3 expression (an apoptotic marker), and Modified Tarlov Score results, certolizumab effectively suppressed inflammation-induced neural apoptosis and alleviated locomotor deficits.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Certolizumab treatment exerts a neuroprotective effect against secondary damage in SCI through the inhibition of neuroinflammation and apoptosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10787-025-01674-5","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T13:22:10Z","timestamp":1740576130000},"page":"1517-1529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Certolizumab enhances spinal cord injury recovery in rats through inhibition of the TNF-\u03b1 signaling pathway and neuronal apoptosis"],"prefix":"10.1007","volume":"33","author":[{"given":"Ozan","family":"K\u00fc\u00e7\u00fckatalay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7a\u011flar","family":"T\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7evik","family":"G\u00fcrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6k\u00e7e Ceren","family":"Ku\u015f\u00e7u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Eren","family":"Y\u00fcnc\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130nan\u00e7","family":"Karakoyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Ak\u015fit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"Sar\u0131kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Karada\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2402-0722","authenticated-orcid":false,"given":"Mahmut","family":"\u00c7amlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"1674_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/FNEUR.2019.00282","author":"A Alizadeh","year":"2019","unstructured":"Alizadeh A, Dyck SM, Karimi-Abdolrezaee S (2019) Traumatic spinal cord injury: an overview of pathophysiology , models and acute injury mechanisms. Front Neurol. https:\/\/doi.org\/10.3389\/FNEUR.2019.00282","journal-title":"Front Neurol"},{"key":"1674_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3340\/JKNS.2015.57.2.73","volume":"57","author":"A\u00d6 B\u00f6rcek","year":"2015","unstructured":"B\u00f6rcek A\u00d6, \u00c7ivi S, \u00d6cal \u00d6, G\u00fclbahar \u00d6 (2015) Effects of tumor necrosis factor alpha blocker adalimumab in experimental spinal cord injury. J Korean Neurosurg Soc 57:73. https:\/\/doi.org\/10.3340\/JKNS.2015.57.2.73","journal-title":"J Korean Neurosurg Soc"},{"key":"1674_CR3","doi-asserted-by":"publisher","first-page":"e288","DOI":"10.1016\/J.WNEU.2019.02.043","volume":"126","author":"M Camlar","year":"2019","unstructured":"Camlar M, Turk \u00c7, Buhur A et al (2019) Does decompressive duraplasty have a neuroprotective effect on spinal trauma?: An experimental study. World Neurosurg 126:e288\u2013e294. https:\/\/doi.org\/10.1016\/J.WNEU.2019.02.043","journal-title":"World Neurosurg"},{"key":"1674_CR4","doi-asserted-by":"publisher","first-page":"19018","DOI":"10.3390\/IJMS151019018","volume":"15","author":"CK Chang","year":"2014","unstructured":"Chang CK, Chou W, Lin HJ et al (2014) Exercise preconditioning protects against spinal cord injury in rats by upregulating neuronal and astroglial heat shock protein. Int J Mol Sci 15:19018\u201319036. https:\/\/doi.org\/10.3390\/IJMS151019018","journal-title":"Int J Mol Sci"},{"key":"1674_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12974-018-1193-6","volume":"15","author":"S Chen","year":"2018","unstructured":"Chen S, Ye J, Chen X et al (2018) Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-\u03baB pathway dependent of HDAC3. J Neuroinflammation 15:150. https:\/\/doi.org\/10.1186\/s12974-018-1193-6","journal-title":"J Neuroinflammation"},{"key":"1674_CR6","doi-asserted-by":"publisher","DOI":"10.1055\/A-2111-5698","author":"DM Croci","year":"2024","unstructured":"Croci DM, Shipman H, Monsour M et al (2024) Interleukin-6 in spinal cord injury: could immunomodulation replace immunosuppression in the management of acute traumatic spinal cord injuries? J Neurol Surg A Cent Eur Neurosurg. https:\/\/doi.org\/10.1055\/A-2111-5698","journal-title":"J Neurol Surg A Cent Eur Neurosurg"},{"key":"1674_CR7","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1136\/RMDOPEN-2019-000942","volume":"5","author":"JR Curtis","year":"2019","unstructured":"Curtis JR, Mariette X, Gaujoux-Viala C et al (2019) Original article: Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn\u2019s disease: a pooled analysis of 11 317 patients across clinical trials. RMD Open 5:942. https:\/\/doi.org\/10.1136\/RMDOPEN-2019-000942","journal-title":"RMD Open"},{"key":"1674_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3399\/BJGP16X684433","volume":"66","author":"A Davis","year":"2016","unstructured":"Davis A, Robson J (2016) The dangers of NSAIDs: look both ways. Br J Gen Pract 66:172. https:\/\/doi.org\/10.3399\/BJGP16X684433","journal-title":"Br J Gen Pract"},{"key":"1674_CR9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/S40259-016-0197-Y\/TABLES\/5","volume":"30","author":"ED Deeks","year":"2016","unstructured":"Deeks ED (2016) Certolizumab pegol: a review in inflammatory autoimmune diseases. BioDrugs 30:607\u2013617. https:\/\/doi.org\/10.1007\/S40259-016-0197-Y\/TABLES\/5","journal-title":"BioDrugs"},{"key":"1674_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/PRP2.817","volume":"9","author":"S Dro\u017cd\u017cal","year":"2021","unstructured":"Dro\u017cd\u017cal S, Lechowicz K, Szostak B et al (2021) Kidney damage from nonsteroidal anti-inflammatory drugs\u2014Myth or truth? Review of selected literature. Pharmacol Res Perspect 9:e00817. https:\/\/doi.org\/10.1002\/PRP2.817","journal-title":"Pharmacol Res Perspect"},{"key":"1674_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.clinbiochem.2003.11.015","volume":"37","author":"O Erel","year":"2004","unstructured":"Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37:277\u2013285. https:\/\/doi.org\/10.1016\/j.clinbiochem.2003.11.015","journal-title":"Clin Biochem"},{"key":"1674_CR12","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/J.CLINBIOCHEM.2005.08.008","volume":"38","author":"O Erel","year":"2005","unstructured":"Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103\u20131111. https:\/\/doi.org\/10.1016\/J.CLINBIOCHEM.2005.08.008","journal-title":"Clin Biochem"},{"key":"1674_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/J.TIPS.2010.11.009","volume":"32","author":"E Esposito","year":"2011","unstructured":"Esposito E, Cuzzocrea S (2011) Anti-TNF therapy in the injured spinal cord. Trends Pharmacol Sci 32:107\u2013115. https:\/\/doi.org\/10.1016\/J.TIPS.2010.11.009","journal-title":"Trends Pharmacol Sci"},{"key":"1674_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176267","volume":"964","author":"X Fan","year":"2024","unstructured":"Fan X, Zang C, Lao K et al (2024) Neuroprotective effects of tetramethylpyrazine on spinal cord injury-Related neuroinflammation mediated by P2X7R\/NLRP3 interaction. Eur J Pharmacol 964:176267. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176267","journal-title":"Eur J Pharmacol"},{"key":"1674_CR15","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1124\/jpet.105.097188","volume":"316","author":"T Genovese","year":"2006","unstructured":"Genovese T, Mazzon E, Crisafulli C et al (2006) Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J Pharmacol Exp Ther 316:1006\u20131016. https:\/\/doi.org\/10.1124\/jpet.105.097188","journal-title":"J Pharmacol Exp Ther"},{"key":"1674_CR16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/J.NEUROSCIENCE.2007.06.059","volume":"150","author":"T Genovese","year":"2007","unstructured":"Genovese T, Mazzon E, Crisafulli C et al (2007) Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma. Neuroscience 150:168\u2013181. https:\/\/doi.org\/10.1016\/J.NEUROSCIENCE.2007.06.059","journal-title":"Neuroscience"},{"key":"1674_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.56016\/dahudermj.1146178","volume":"2","author":"H G\u00f6\u011febakan","year":"2022","unstructured":"G\u00f6\u011febakan H, Y\u0131ld\u0131r\u0131m \u00c7etin G (2022) The effect of anti TNF alpha (certolizumab) treatment on insulin resistance, lipid parameters and cardiovascular risk in patients with axial spondyloarthritis (ankylosing spondylitis). Dahuder Med J 2:65\u201372. https:\/\/doi.org\/10.56016\/dahudermj.1146178","journal-title":"Dahuder Med J"},{"key":"1674_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ab.2014.12.007","volume":"473","author":"IV Grishagin","year":"2015","unstructured":"Grishagin IV (2015) Automatic cell counting with ImageJ. Anal Biochem 473:63\u201365. https:\/\/doi.org\/10.1016\/j.ab.2014.12.007","journal-title":"Anal Biochem"},{"key":"1674_CR19","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s43032-022-00878-2","volume":"29","author":"I Gunusen","year":"2022","unstructured":"Gunusen I, Akdemir A, Gurel C et al (2022) The effects of different pressure pneumoperitoneum models created by standard or heated-humidified CO2 insufflation on ovary and peritoneum: an experimental study in rats. Reprod Sci 29:1197\u20131208. https:\/\/doi.org\/10.1007\/s43032-022-00878-2","journal-title":"Reprod Sci"},{"key":"1674_CR20","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1177\/0960327119862006","volume":"38","author":"C Gurel","year":"2019","unstructured":"Gurel C, Kuscu GC, Buhur A et al (2019) Fluvastatin attenuates doxorubicin-induced testicular toxicity in rats by reducing oxidative stress and regulating the blood-testis barrier via mTOR signaling pathway. Hum Exp Toxicol 38:1329\u20131343. https:\/\/doi.org\/10.1177\/0960327119862006","journal-title":"Hum Exp Toxicol"},{"key":"1674_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3171\/2020.2.SPINE191439","volume":"33","author":"G G\u00fcrkan","year":"2020","unstructured":"G\u00fcrkan G, Sayin M, Kizmazoglu C et al (2020) Evaluation of the neuroprotective effects of ozone in an experimental spine injury model. J Neurosurg Spine 33:406\u2013414. https:\/\/doi.org\/10.3171\/2020.2.SPINE191439","journal-title":"J Neurosurg Spine"},{"key":"1674_CR22","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/J.JOCN.2010.04.027","volume":"17","author":"C Guven","year":"2010","unstructured":"Guven C, Borcek AO, Cemil B et al (2010) Neuroprotective effects of infliximab in experimental spinal cord ischemic injury. J Clin Neurosci 17:1563\u20131567. https:\/\/doi.org\/10.1016\/J.JOCN.2010.04.027","journal-title":"J Clin Neurosci"},{"key":"1674_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/J.JCHEMNEU.2017.08.001","volume":"87","author":"E Hayta","year":"2018","unstructured":"Hayta E, Elden H (2018) Acute spinal cord injury: a review of pathophysiology and potential of non-steroidal anti-inflammatory drugs for pharmacological intervention. J Chem Neuroanat 87:25\u201331. https:\/\/doi.org\/10.1016\/J.JCHEMNEU.2017.08.001","journal-title":"J Chem Neuroanat"},{"key":"1674_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/J.INTIMP.2022.109616","volume":"114","author":"Z Hu","year":"2023","unstructured":"Hu Z, Xuan L, Wu T et al (2023) Taxifolin attenuates neuroinflammation and microglial pyroptosis via the PI3K\/Akt signaling pathway after spinal cord injury. Int Immunopharmacol 114:109616. https:\/\/doi.org\/10.1016\/J.INTIMP.2022.109616","journal-title":"Int Immunopharmacol"},{"key":"1674_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2023.107202","volume":"232","author":"X Huang","year":"2023","unstructured":"Huang X, Chen X, Li Q et al (2023) Loganin reduces neuroinflammation and promotes functional recovery after spinal cord injury through inhibiting NF-\u03baB\/NLRP3 signalling. Toxicon 232:107202. https:\/\/doi.org\/10.1016\/j.toxicon.2023.107202","journal-title":"Toxicon"},{"key":"1674_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ANI9100754","author":"RC Hubrecht","year":"2019","unstructured":"Hubrecht RC, Carter E (2019) The 3Rs and humane experimental technique: implementing change. Anim an Open Access J from MDPI. https:\/\/doi.org\/10.3390\/ANI9100754","journal-title":"Anim an Open Access J from MDPI"},{"key":"1674_CR27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/ard.2006.062497","volume":"66","author":"LTH Jacobsson","year":"2007","unstructured":"Jacobsson LTH, Turesson C, Nilsson J\u00c5 et al (2007) Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis. Ann Rheum Dis 66:670\u2013675. https:\/\/doi.org\/10.1136\/ard.2006.062497","journal-title":"Ann Rheum Dis"},{"key":"1674_CR28","doi-asserted-by":"publisher","DOI":"10.3906\/sag-2102-200","author":"B Kinali","year":"2021","unstructured":"Kinali B, \u00d6zdemir N, Karada\u011f A et al (2021) Effect of humic acid on oxidative stress and neuroprotection in traumatic spinal cord injury: an experimental study. Turkish J Med Sci. https:\/\/doi.org\/10.3906\/sag-2102-200","journal-title":"Turkish J Med Sci"},{"key":"1674_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1590\/1806-9282.65.2.204","volume":"65","author":"MA Kosekli","year":"2019","unstructured":"Kosekli MA, Herek \u00d6, Ozmen \u00d6, Sahinduran S (2019) Ameliorative effect of certolizumab on experimentally induced acute necrotic pancreatitis in rats. Rev Assoc Med Bras 65:204\u2013210. https:\/\/doi.org\/10.1590\/1806-9282.65.2.204","journal-title":"Rev Assoc Med Bras"},{"key":"1674_CR30","doi-asserted-by":"publisher","DOI":"10.1080\/01480545.2022.2043351","author":"GC Ku\u015f\u00e7u","year":"2022","unstructured":"Ku\u015f\u00e7u GC, G\u00fcrel \u00c7, Buhur A et al (2022) Fluvastatin alleviates doxorubicin-induced cardiac and renal toxicity in rats via regulation of oxidative stress, inflammation, and apoptosis associated genes expressions. Drug Chem Toxicol. https:\/\/doi.org\/10.1080\/01480545.2022.2043351","journal-title":"Drug Chem Toxicol"},{"key":"1674_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/2192568220901689","volume":"11","author":"MJ Lambrechts","year":"2020","unstructured":"Lambrechts MJ, Cook JL (2020) Nonsteroidal anti-inflammatory drugs and their neuroprotective role after an acute spinal cord injury: a systematic review of animal models. Glob Spine J 11:365. https:\/\/doi.org\/10.1177\/2192568220901689","journal-title":"Glob Spine J"},{"key":"1674_CR32","doi-asserted-by":"publisher","first-page":"8552","DOI":"10.3390\/CIMB45110539","volume":"45","author":"A Larrea","year":"2023","unstructured":"Larrea A, Elexpe A, D\u00edez-Mart\u00edn E et al (2023) Neuroinflammation in the evolution of motor function in stroke and trauma patients: treatment and potential biomarkers. Curr Issues Mol Biol 45:8552. https:\/\/doi.org\/10.3390\/CIMB45110539","journal-title":"Curr Issues Mol Biol"},{"key":"1674_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/RHU.0000000000000627","volume":"24","author":"K Lazarewicz","year":"2018","unstructured":"Lazarewicz K, Shaw S, Haque S (2018) Certolizumab pegol-induced heart failure. J Clin Rheumatol 24:55\u201356. https:\/\/doi.org\/10.1097\/RHU.0000000000000627","journal-title":"J Clin Rheumatol"},{"key":"1674_CR34","doi-asserted-by":"publisher","first-page":"13833","DOI":"10.3390\/IJMS232213833","volume":"23","author":"R Lima","year":"2022","unstructured":"Lima R, Monteiro A, Salgado AJ et al (2022) Pathophysiology and therapeutic approaches for spinal cord injury. Int J Mol Sci 23:13833. https:\/\/doi.org\/10.3390\/IJMS232213833","journal-title":"Int J Mol Sci"},{"key":"1674_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/IJMS222413577","volume":"22","author":"N Lukacova","year":"2021","unstructured":"Lukacova N, Kisucka A, Bimbova KK et al (2021) Glial-neuronal interactions in pathogenesis and treatment of spinal cord injury. Int J Mol Sci 22:22. https:\/\/doi.org\/10.3390\/IJMS222413577","journal-title":"Int J Mol Sci"},{"issue":"43","key":"1674_CR36","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/S10571-022-01229-0","volume":"433","author":"MC Lund","year":"2022","unstructured":"Lund MC, Clausen BH, Brambilla R, Lambertsen KL (2022) The role of tumor necrosis factor following spinal cord injury: a systematic review. Cell Mol Neurobiol 433(43):925\u2013950. https:\/\/doi.org\/10.1007\/S10571-022-01229-0","journal-title":"Cell Mol Neurobiol"},{"key":"1674_CR37","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3390\/BIOLOGY12060845\/S1","volume":"12","author":"MC Lund","year":"2023","unstructured":"Lund MC, Ellman DG, Nielsen PV et al (2023) Selective inhibition of soluble tumor necrosis factor alters the neuroinflammatory response following moderate spinal cord injury in mice. Biology (Basel) 12:845. https:\/\/doi.org\/10.3390\/BIOLOGY12060845\/S1","journal-title":"Biology (Basel)"},{"key":"1674_CR38","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.neuroscience.2009.05.049","volume":"162","author":"M Mir","year":"2009","unstructured":"Mir M, Asensio VJ, Tolosa L et al (2009) Tumor necrosis factor alpha and interferon gamma cooperatively induce oxidative stress and motoneuron death in rat spinal cord embryonic explants. Neuroscience 162:959\u2013971. https:\/\/doi.org\/10.1016\/j.neuroscience.2009.05.049","journal-title":"Neuroscience"},{"key":"1674_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/JNR.22734","volume":"90","author":"YJ Moon","year":"2012","unstructured":"Moon YJ, Lee JY, Oh MS et al (2012) Inhibition of inflammation and oxidative stress by Angelica dahuricae radix extract decreases apoptotic cell death and improves functional recovery after spinal cord injury. J Neurosci Res 90:243\u2013256. https:\/\/doi.org\/10.1002\/JNR.22734","journal-title":"J Neurosci Res"},{"key":"1674_CR40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/J.EXPNEUROL.2010.04.020","volume":"224","author":"M Mukaino","year":"2010","unstructured":"Mukaino M, Nakamura M, Yamada O et al (2010) Anti-IL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation. Exp Neurol 224:403\u2013414. https:\/\/doi.org\/10.1016\/J.EXPNEUROL.2010.04.020","journal-title":"Exp Neurol"},{"key":"1674_CR41","doi-asserted-by":"publisher","first-page":"8689","DOI":"10.3390\/ijms24108689","volume":"24","author":"N M\u00fcller","year":"2023","unstructured":"M\u00fcller N, Scheld M, Voelz C et al (2023) Lipocalin-2 deficiency diminishes canonical NLRP3 inflammasome formation and IL-1\u03b2 production in the subacute phase of spinal cord injury. Int J Mol Sci 24:8689. https:\/\/doi.org\/10.3390\/ijms24108689","journal-title":"Int J Mol Sci"},{"key":"1674_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/and.13667","volume":"52","author":"F Ok","year":"2020","unstructured":"Ok F, Kaplan HM, Kizilgok B, Demir E (2020) Protective effect of alpha-linolenic acid on lipopolysaccharide-induced orchitis in mice. Andrologia 52:e13667. https:\/\/doi.org\/10.1111\/and.13667","journal-title":"Andrologia"},{"key":"1674_CR43","first-page":"71","volume":"3","author":"X Rao","year":"2013","unstructured":"Rao X, Huang X, Zhou Z, Lin X (2013) An improvement of the 2\u02c6(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath 3:71\u201385","journal-title":"Biostat Bioinforma Biomath"},{"key":"1674_CR44","doi-asserted-by":"publisher","first-page":"1084101","DOI":"10.3389\/FIMMU.2022.1084101\/BIBTEX","volume":"13","author":"RC Sterner","year":"2023","unstructured":"Sterner RC, Sterner RM (2023) Immune response following traumatic spinal cord injury: pathophysiology and therapies. Front Immunol 13:1084101. https:\/\/doi.org\/10.3389\/FIMMU.2022.1084101\/BIBTEX","journal-title":"Front Immunol"},{"key":"1674_CR45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-1-4615-0123-7_3","volume":"513","author":"G Stoll","year":"2002","unstructured":"Stoll G, Jander S, Schroeter M (2002) Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Adv Exp Med Biol 513:87\u2013113. https:\/\/doi.org\/10.1007\/978-1-4615-0123-7_3","journal-title":"Adv Exp Med Biol"},{"key":"1674_CR46","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1006\/EXNR.1998.6835","volume":"152","author":"WJ Streit","year":"1998","unstructured":"Streit WJ, Semple-Rowland SL, Hurley SD et al (1998) Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp Neurol 152:74\u201387. https:\/\/doi.org\/10.1006\/EXNR.1998.6835","journal-title":"Exp Neurol"},{"key":"1674_CR47","first-page":"120","volume":"54","author":"J Tannenbaum","year":"2015","unstructured":"Tannenbaum J, Bennett BT (2015) Russell and burch\u2019s 3Rs then and now: the need for clarity in definition and purpose. J Am Assoc Lab Anim Sci 54:120","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"1674_CR48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.14744\/TJTES.2024.03660","volume":"30","author":"\u00c7 T\u00fcrk","year":"2024","unstructured":"T\u00fcrk \u00c7, Bahad\u0131r S, Camlar M et al (2024) Effects of lercanidipine on traumatic spinal cord injury: an experimental study. Turkish J Trauma Emerg Surg 30:73. https:\/\/doi.org\/10.14744\/TJTES.2024.03660","journal-title":"Turkish J Trauma Emerg Surg"},{"key":"1674_CR49","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/B978-0-323-31696-5.00063-2","volume":"1","author":"Z Tutuncu","year":"2017","unstructured":"Tutuncu Z, Kavanaugh A (2017) Anti-cytokine therapies. Kelley firestein\u2019s textb rheumatol Vol 1\u20132. Tenth Ed 1:999\u20131019. https:\/\/doi.org\/10.1016\/B978-0-323-31696-5.00063-2","journal-title":"Tenth Ed"},{"key":"1674_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/J.MSEC.2021.112624","volume":"133","author":"B Wang","year":"2022","unstructured":"Wang B, Chang M, Zhang R et al (2022) Spinal cord injury target-immunotherapy with TNF-\u03b1 autoregulated and feedback-controlled human umbilical cord mesenchymal stem cell derived exosomes remodelled by CRISPR\/Cas9 plasmid. Biomater Adv 133:112624. https:\/\/doi.org\/10.1016\/J.MSEC.2021.112624","journal-title":"Biomater Adv"},{"key":"1674_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/J.PRP.2023.154331","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang X, Zou Z et al (2023) Conditioned medium from bone marrow mesenchymal stem cells relieves spinal cord injury through suppression of Gal-3\/NLRP3 and M1 microglia\/macrophage polarization. Pathol Res Pract. https:\/\/doi.org\/10.1016\/J.PRP.2023.154331","journal-title":"Pathol Res Pract"},{"key":"1674_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112498","volume":"137","author":"D Wang","year":"2024","unstructured":"Wang D, Zhao J, Zhang J et al (2024) Targeting TNF-\u03b1: The therapeutic potential of certolizumab pegol in the early period of cerebral ischemia reperfusion injury in mice. Int Immunopharmacol 137:112498. https:\/\/doi.org\/10.1016\/j.intimp.2024.112498","journal-title":"Int Immunopharmacol"},{"key":"1674_CR53","doi-asserted-by":"publisher","first-page":"112031","DOI":"10.1016\/J.INTIMP.2024.112031","volume":"133","author":"GQ Xia","year":"2024","unstructured":"Xia GQ, Xu M, Sun C et al (2024) Elevated microRNA-214\u20133p level ameliorates neuroinflammation after spinal cord ischemia\u2013reperfusion injury by inhibiting Nmb\/Cav3.2 pathway. Int Immunopharmacol 133:112031. https:\/\/doi.org\/10.1016\/J.INTIMP.2024.112031","journal-title":"Int Immunopharmacol"},{"key":"1674_CR54","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0169-328X(98)00142-9","volume":"59","author":"J Xu","year":"1998","unstructured":"Xu J, Fan G, Chen S et al (1998) Methylprednisolone inhibition of TNF-\u03b1 expression and NF-kB activation after spinal cord injury in rats. Mol Brain Res 59:135\u2013142. https:\/\/doi.org\/10.1016\/S0169-328X(98)00142-9","journal-title":"Mol Brain Res"},{"key":"1674_CR55","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/SJ.SC.3101674","volume":"43","author":"W Xu","year":"2005","unstructured":"Xu W, Chi L, Xu R et al (2005) Increased production of reactive oxygen species contributes to motor neuron death in a compression mouse model of spinal cord injury. Spinal Cord 43:204\u2013213. https:\/\/doi.org\/10.1038\/SJ.SC.3101674","journal-title":"Spinal Cord"},{"key":"1674_CR56","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12056","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Al Mamun A, Yuan Y et al (2021) Acute spinal cord injury: pathophysiology and pharmacological intervention (Review). Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2021.12056","journal-title":"Mol Med Rep"},{"key":"1674_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/CNS.14781","author":"M Zhang","year":"2024","unstructured":"Zhang M, Han X, Yan L et al (2024) Inflammatory response in traumatic brain and spinal cord injury: the role of XCL1-XCR1 axis and T cells. CNS Neurosci Ther. https:\/\/doi.org\/10.1111\/CNS.14781","journal-title":"CNS Neurosci Ther"},{"key":"1674_CR58","doi-asserted-by":"publisher","DOI":"10.1177\/10815589241254044","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Bai Y, Zhang P et al (2024) Propofol alleviates spinal cord ischemia-reperfusion injury by preserving PI3K\/AKT\/GIT1 axis. J Investig Med. https:\/\/doi.org\/10.1177\/10815589241254044","journal-title":"J Investig Med"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01674-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01674-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01674-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T13:19:15Z","timestamp":1742303955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01674-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1674"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01674-5","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"15 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The experimental protocol was evaluated and approved by Ege University, Local Ethics Committee for Animal Experiments (Approval No\/Approval Date: 2016\u2013085\/28 December 2022).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}